Pharmaceutical company Merck says that it will stop using chimpanzees in its biomedical research efforts, according to the Wall Street Journal. The company says newer technologies and alternate approaches can replace the use of chimpanzees in drug research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Chimps' Retirement

This Week in Science

Changes to Gut Bugs

Academic Image

Long-time Companion

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.